Vitamin E for NASH Treatment in HIV Infected Individuals
Sponsor: Indiana University School of Medicine
Terminated
lack of coordinator resources and lack of access to study resources during and due to the COVID pandemic
Other terminated trials from Indiana University School of Medicine
- Respiration Disorders · Phase NA · Dec 2019
- Pain, Postoperative · Phase PHASE2 · May 2017
- Intermittent Exotropia · Phase NA · Dec 2016
- Biliary Tract Cancer · Aug 2015
- Coronary Artery Disease · Phase NA · Aug 2014
See all terminations from Indiana University School of Medicine
A PHASE2 clinical study on HIV Infections and NAFLD, this trial is terminated or withdrawn. The trial is conducted by Indiana University School of Medicine and has accumulated 10 data snapshots since 2019. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Aug 2023 — Jul 2024 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Mar 2023 — Aug 2023 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Feb 2022 — Mar 2023 [monthly]
Recruiting PHASE2
▶ Show 5 earlier versions
-
Mar 2021 — Feb 2022 [monthly]
Recruiting PHASE2
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE2
-
Jan 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Nov 2018 — Jan 2020 [monthly]
Recruiting PHASE2
-
Oct 2018 — Nov 2018 [monthly]
Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Indiana University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .